112 hits for »HTA «
…a number of issues the new EU HTA procedure was meant to tackle[1], the most important being divergent HTA processes and methodologies in Member States and the duplication of work for national HTA bodies and developers. Together, these issues impede and distort market access and…
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have concerns on the current direction of the implementation of the EU HTA Regulation. We are firmly convinced that the input from patient organizations, healthcare professionals, industry and HTA…
…as possible guidance on (High) Unmet Needs and how this relates to EU-level and national level HTA work. According to van den Steen, “A well-coordinated relationship between the Pharmaceutical Package and HTA is essential for success”. According to van den Steen, the EU HTA procedure…
…draft Implementing Act for the new EU HTA procedure. The draft Implementing Act (IA) on Joint Clinical Assessment (JCA) of medicinal products, prepared by Member States’ “Comitology” Committee on Health Technology Assessment (HTA) with the support of the European Commission, has recently been published for…
…EU HTA Regulation: Preparing for a Changing Landscape 25 September | Industry Only Dive into the EU HTA Regulation landscape at the DIA HTA Forum’s Pre-Forum Workshop, exclusive for industry attendees. Explore strategies for navigating the complexity of future Joint Clinical Assessments (JCAs) and for…
…biotech company Antje Behring, Department Head Pharmaceuticals, G-BA (German Federal Joint Committee, Germany’s HTA Agency): The planned Europe-wide HTA harmonization from the perspective of a European HTA-Agency. Norbert Gerbsch, Department Head Public Affairs, IGES Institut (moderator): Integration of the harmonized EU-HTA procedure into the clinical…
…will be made subject to the EU HTA which pharmaceuticals will be subject to the EU HTA procedure starting in 2025 Don’t miss your opportunity to get ahead and fully understand the implications of the EU HTA system in 2025. Secure your free place here…
Sounds of Science – Episode 12 The new EU HTA Procedure: Getting it right to improve patients’ access to innovative therapies With the entry into force of the EU HTA Regulation in January 2022, the European Commission and EUnetHTA21, a consortium of Member States HTA…
Join our workshop to explore the impact of EU HTA on pharmaceutical market access in Europe. Senior executives will gain strategic insights from key markets—France, Germany, and Spain—through expert analysis and real-life case studies. Learn how to navigate EU HTA challenges and leverage real-world data…
Join EUNetHTA, EUCOPE and MAP Patient Access as they discuss the implementation of the EU HTA system in 2025. This webinar will help attendees to: Understand details about the stepwise entry into force of the EU HTA starting in January 2025 Learn how EUnetHTA21 will…
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information